
Atavistik Bio
Operator of a biopharmaceutical company intended to focus on the discovery and development of novel therapies for metabolic diseases and cancer. The company's platform specializes in discovering drugs...
Valuation
$0
Share Price
N/A
Total Raised
$220M
Last Round
N/A